Dr. Anil Gulati is the Chairman and Chief Executive Officer of Pharmazz Inc. He has over 38 years of experience in the pharmaceutical industry and is a leading figure in the development and commercialization of innovative drug products in critical care medicine. Dr. Gulati led the discovery, development, and launch of Centhaquine Citrate (Lyfaquin), a treatment for hypovolemic shock. He holds 54 issued patents and has received numerous awards, including the Paul R. Dawson Biotechnology Award and the International Ranbaxy Research Award12. Additionally, he is a Professor Emeritus at Midwestern University and a United States Fulbright Scholar.